R&D Changing Faces - Pharma and biotech - October 2025 From high-profile resignations to strategic appointments, October was a buzzy month for pharma industry personnel news.
R&D Beyond animal testing: How human data trials are reshaping d... Researchers are beginning to imagine a future in which development pipelines are more predictive, more efficient, and ultimately more humane.
R&D From physics to pharma: How Aqemia is reinventing the future... The UK life sciences sector has long been a crucible for innovation, blending academic excellence with a thriving ecosystem of biotech and pharmaceutical enterprises.
R&D Sponsored 12 Questions With Trenton M. Johnson Find out more about Senior Director of CMC Portfolio Management, Thermo Fisher Scientific, Trenton M. Johnson in a new 12 Questions With.
R&D Leveraging AI agents to eliminate ‘white space’ in clinical ... Human-AI collaboration has the potential to mitigate gross productivity gaps and establish a new standard of clinical trial efficiency.
R&D ESMO25: On partnerships between pharma and diagnostic develo... Jane Li, Senior Director of Pharma CDx and CRO Partnership, Clinical Next Generation Sequencing Business, at Thermo Fisher Scientific discusses CDx.
Digital On AI and computational support of biochemistry, with Alan R... Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.
Sales & Marketing Sponsored The AI imperative: Establishing the standard for modern clin... The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.
